30 Day Trial

Medicrea Growth Driven by U.S. Sales of Patient-Specific Implants

Share:

Medicrea reports 3Q19 revenue of €8.2MM (USD $9.2MM), +12.3% vs. 3Q18.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.